Skip to main content
Premium Trial:

Request an Annual Quote

Genotyping Service, Product Sales Drive Orchid s Q3 Revenues Up 51 Pct

NEW YORK, Nov. 8 – Orchid BioSciences of Princeton, NJ, said Thursday its third quarter revenues rose 51 percent in the third quarter to $7.4 million, compared with $4.9 million, in the year ago period. 

Orchid attributed the increase to revenues from its genotyping services and product sales.

"We continued to deliver on our unique business strategy by achieving strong revenue growth while successfully launching a major new product, forming new commercial collaborations, signing on new customers for our leading genotyping products and services, and strengthening our technology IP portfolio," Dale Pfost, Orchid’s CEO, said in a statement. 

Orchid said that going forward it expected to see a continued increase in its revenues. The company said that its acquisition of Lifecodes, a developer of genomics tests, would contribute to revenues, which are estimated to total more than $50 million in 2002.

In addition, the company’s new diagnostics unit is expected to generate more than $12 million in revenues in 2002. 

The higher revenues came amidst a surge in operating expenses, which more than tripled to $49.7 million, compared with $15.1 million, for the third quarter of 2000.

Orchid said the increase came primarily from higher research and development and product development activities.

Orchid’s net losses also widened sharply. Including charges, the company posted a third quarter net loss of $41.9 million, or $1.06 a share, compared with $9 million, or 27 cents a share, in the year ago quarter. 

Excluding non-cash compensation, certain research and development and other one-time charges, Orchid’s net losses would have totaled would 32 cents a share, compared with 18 cents a share a year ago.

  The company expects to be cash accretive in about 12 months. 

At the end of the month Orchid had cash, cash equivalents and short-term investments totaling $52.7 million. 

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.